Back |
home / stock / cerc / cerc message board
Subject | By | Source | When |
---|---|---|---|
Weeee | europtiger | investorshub | 01/23/2018 4:34:46 PM |
Running nice | europtiger | investorshub | 01/22/2018 2:51:05 PM |
$2.7 . bouncer . $CERC | axelvento | investorshub | 01/15/2018 1:31:39 PM |
Happy New Year to all of Cerecor Inc | cash_cow1 | investorshub | 01/02/2018 4:38:05 PM |
Back from the Christmas Holidays. Back in at | cash_cow1 | investorshub | 01/02/2018 4:36:03 PM |
Market maker magic from 4,10 to 3,80's with | europtiger | investorshub | 12/27/2017 3:40:55 PM |
Wooowzaaaaa | europtiger | investorshub | 12/27/2017 3:40:03 PM |
New 52 week high | europtiger | investorshub | 12/27/2017 2:50:34 PM |
Go $CERC | europtiger | investorshub | 12/27/2017 2:39:16 PM |
true monster $$$$$$ . $CERC | axelvento | investorshub | 12/26/2017 6:13:20 PM |
axelvento grazie che hai postato mesi fa su | Expresso123 | investorshub | 12/26/2017 4:35:29 PM |
2018 going be huge not worth flipping | Expresso123 | investorshub | 12/26/2017 4:16:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Topline results from planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa expected in 2026 Cash on hand of approximately $110 million as of March 31, 2024 with expected cash runway into 2027 WAYNE, Pa. and ROCKVILLE, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeut...
Appointments include industry veterans Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent Directors Board of Director appointments in conjunction with Avalo’s recent acquisition of AVTX-009, an anti-IL-1β mAb, and up to $185 million private placement financ...
Acquired AVTX-009, Phase-2 ready anti-IL-1β mAb, in March 2024 Increased cash position with private placement financing in March 2024 providing up to $185 million, including initial upfront investment of $115.6 million Topline results from planned Phase 2 trial of AVTX-00...